Adebayo Alonge explains how RxAll's AI-driven spectrometer authenticates medicines

Adebayo “Ade” Alonge is the Nigerian co-founder of RxAll, a platform which provides patients in the developing world with authenticated and verified medicines. Prior to this, Ade was a strategy consultant with the Boston Consulting Group, and before that, he spent eight years working a Sanofi, Roche, and BASF. In this absorbing, not-so-quick chat with Andile Masuku, Ade unpacks the state of play within Nigeria's pharmaceutical mass market, and explains how RxAll is enabling direct access to affordable, high-quality medicines while helping to reshape drug purchasing habits within markets rife with counterfeit product.

There are no comments yet.

Please log in to write the first comment.